David W Ouyang

Summary

Publications

  1. ncbi Obstetric outcomes in pregnant women with congenital heart disease
    David W Ouyang
    Department of Obstetrics and Gynecology, Brigham and Women s Hospital, Harvard Medical School, USA
    Int J Cardiol 144:195-9. 2010
  2. ncbi Increased risk of hepatotoxicity in HIV-infected pregnant women receiving antiretroviral therapy independent of nevirapine exposure
    David W Ouyang
    Division of Maternal Fetal Medicine, Brigham and Women s Hospital, USA
    AIDS 23:2425-30. 2009
  3. ncbi Lack of increased hepatotoxicity in HIV-infected pregnant women receiving nevirapine compared with other antiretrovirals
    David W Ouyang
    Division of Maternal Fetal Medicine, Brigham and Women s Hospital, Boston, Massachusetts, USA
    AIDS 24:109-14. 2010
  4. ncbi Pregnancy outcomes in women with congenital heart disease
    Paul Khairy
    Boston Adult Congenital Heart Service, Brigham and Women s Hospital, Boston, MA, USA
    Circulation 113:517-24. 2006
  5. ncbi Obstetric complications of fibroids
    David W Ouyang
    Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women s Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA
    Obstet Gynecol Clin North Am 33:153-69. 2006

Detail Information

Publications5

  1. ncbi Obstetric outcomes in pregnant women with congenital heart disease
    David W Ouyang
    Department of Obstetrics and Gynecology, Brigham and Women s Hospital, Harvard Medical School, USA
    Int J Cardiol 144:195-9. 2010
    ..In addition, a secondary aim was to assess the impact of avoiding Valsalva on obstetrical outcomes, an intervention commonly recommended, but never studied...
  2. ncbi Increased risk of hepatotoxicity in HIV-infected pregnant women receiving antiretroviral therapy independent of nevirapine exposure
    David W Ouyang
    Division of Maternal Fetal Medicine, Brigham and Women s Hospital, USA
    AIDS 23:2425-30. 2009
    ..To estimate whether the association between nevirapine (NVP) and hepatotoxicity differs according to pregnancy status in HIV-infected women...
  3. ncbi Lack of increased hepatotoxicity in HIV-infected pregnant women receiving nevirapine compared with other antiretrovirals
    David W Ouyang
    Division of Maternal Fetal Medicine, Brigham and Women s Hospital, Boston, Massachusetts, USA
    AIDS 24:109-14. 2010
    ..To estimate whether HIV-infected pregnant women were at an increased risk of hepatotoxicity when taking nevirapine (NVP)-containing regimens compared with HIV-infected pregnant women taking antiretroviral therapy (ART) not containing NVP...
  4. ncbi Pregnancy outcomes in women with congenital heart disease
    Paul Khairy
    Boston Adult Congenital Heart Service, Brigham and Women s Hospital, Boston, MA, USA
    Circulation 113:517-24. 2006
    ..Pregnant women with congenital heart disease are at increased risk for cardiac and neonatal complications, yet risk factors for adverse outcomes are not fully defined...
  5. ncbi Obstetric complications of fibroids
    David W Ouyang
    Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women s Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA
    Obstet Gynecol Clin North Am 33:153-69. 2006
    ..Myomectomy at the time of cesarean delivery is associated with significant morbidity (hemorrhage) and should be pursued with caution and only in select patients...